10 Vertex Pharmaceuticals finance leaders
Richard Wade, Head of Finance, Northern Europe, Australia/NZ, Canada and Global Distributors at Vertex Pharmaceuticals, is one of ten Vertex Pharmaceuticals finance leaders here, alongside people who hold executive director, senior director and finance director roles. A reader can learn how finance leaders work at Vertex Pharmaceuticals from people who have held the role.
Professionals to explore
Christian Alonso
LinkedInExperience: Finance Director, Global Commercial · Vertex Pharmaceuticals
Christian Alonso has been Finance Director, Global Commercial at Vertex Pharmaceuticals in the Boston area since November 2025 and was Finance Director, Commercial Manufacturing & Supply Chain there (2021–2025). Christian Alonso was Finance Director, Global Quality, Capital, Facilities & Engineering and HQ - Global Product Supply at Bristol Myers Squibb (2020–2021).
Ernesto M Massimo
LinkedInExperience: Executive Director, Strategic and BD Finance · Vertex Pharmaceuticals
Ernesto M Massimo has been Executive Director, Strategic and BD Finance at Vertex Pharmaceuticals in the Boston area since February 2024 and was Head of Business Development Finance there (2021–2024). Ernesto M Massimo was Director - BD&L Finance at Novartis (2017–2021) and Finance Manager - R&D at Insulet Corporation (2016–2017).
Gavin Morant-Smith
LinkedInExperience: Senior Finance Director - International FP&A · Vertex Pharmaceuticals
Gavin Morant-Smith has been Senior Finance Director - International FP&A at Vertex Pharmaceuticals in England since September 2020 and was Finance Director - Distributors and Geographic Expansion there (2019–2020). Gavin Morant-Smith held International Controllership - Finance Director at Allergan (2017–2019).
Hugh Donnelly
LinkedInExperience: Senior Director, FP&A · Vertex Pharmaceuticals
Hugh Donnelly has been Senior Director, FP&A at Vertex Pharmaceuticals in the Boston area since February 2022. Hugh Donnelly was Director of Finance at Novartis Science (2014–2022) and Director of Financial Planning and Analysis - Life Science Technologies at PerkinElmer (2013–2015).
Mark Horsch
LinkedInExperience: Senior Director, Commercial Manufacturing and Tech Ops Finance · Vertex Pharmaceuticals
Mark Horsch has been Senior Director, Commercial Manufacturing and Tech Ops Finance at Vertex Pharmaceuticals in Boston since May 2025. Mark Horsch was Vice President, Head of FP&A at Kriya Therapeutics (2023–2025) and Senior Director, Head of Supply Chain Finance and Cost Accounting at Vertex Pharmaceuticals (2021–2022).
Maryse Le Hur-Gurunlian
LinkedInExperience: Senior Director, Regional Finance · Vertex Pharmaceuticals
Maryse Le Hur-Gurunlian has been Senior Director, Regional Finance at Vertex Pharmaceuticals in the Paris area since December 2015. Maryse Le Hur-Gurunlian was Associate Director, EMEA Finance & Business Planning (2014–2015) and Associate Director, EMEA Sales Excellence (2012–2014) at Celgene.
Raul Borja Santos
LinkedInExperience: Senior Director of FP&A - G&A Finance · Vertex Pharmaceuticals
Raul Borja Santos has been Senior Director of FP&A - G&A Finance at Vertex Pharmaceuticals in Boston since June 2025 and was Director of FP&A - CSO there (2024–2025). Raul Borja Santos was Senior Director, Head of FP&A at Decibel Therapeutics (2021–2023) and Finance Head Ecuador & Peru Oncology at Novartis (2016–2018).
Richard Wade
LinkedInExperience: Head of Finance, Northern Europe, Australia/NZ, Canada and Global Distributors · Vertex Pharmaceuticals
Richard Wade has been Head of Finance, Northern Europe, Australia/NZ, Canada and Global Distributors at Vertex Pharmaceuticals in London since July 2024. Richard Wade also held Senior Director of Finance (2019–2024) and Senior Director, Global Business Services (2015–2019) roles at Vertex Pharmaceuticals.
Saya Dempsey
LinkedInExperience: Senior Director, R&D Finance · Vertex Pharmaceuticals
Saya Dempsey has been Senior Director, R&D Finance at Vertex Pharmaceuticals in the Boston area since February 2026. Saya Dempsey also held Senior Director, Head of North America Commercial Finance (2025–2026) and Senior Director, Head of Global Commercial Finance (2022–2025) roles at Vertex Pharmaceuticals.
Ulrich Lentzer
LinkedInExperience: Senior Director Finance DACH & CEE & Global Distributor Region · Vertex Pharmaceuticals
Ulrich Lentzer has been Senior Director Finance DACH & CEE & Global Distributor Region at Vertex Pharmaceuticals in Munich since August 2019 and was Director Finance DACH & CEE there (2016–2019). Ulrich Lentzer was Lead Finance Business Partner NW Europe at GlaxoSmithKline Consumer Healthcare (2014–2016).
Choose the right perspective
Match the person's area, such as business development finance, FP&A, research and development finance, manufacturing finance or regional finance, to the decision you face. Weigh how long each person has held the role and how close their work sits to your question.
Questions to take into the conversation
- 01How did you organize finance support for the business area or region you covered?
- 02What did you learn about forecasting and budgeting around launches and pipeline milestones in your role?
- 03How did you work with commercial, research or manufacturing leaders when plans and spending had to change?
Reaching Vertex Pharmaceuticals finance leaders
How can I contact one of these Vertex Pharmaceuticals finance leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Vertex Pharmaceuticals, based on profile data retrieved on October 17, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Vertex Pharmaceuticals finance leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Vertex Pharmaceuticals finance leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal